(90 days)
Not Found
Not Found
No
The document does not mention AI, ML, or any related terms, and the device description is for a standard blood pressure monitor.
No
The device is described as a non-invasive blood pressure monitor used to collect and measure blood pressure, pulse, and pressure waveform information. Its purpose is diagnostic (measurement) rather than therapeutic (treatment).
Yes
The device collects and measures blood pressure, pulse, and pressure waveform information, which are physiological parameters used to assess a patient's health status. While it doesn't explicitly state 'diagnosis', the collection of clinical information by medical professionals for interpretation strongly implies its use in diagnostic processes.
No
The device description explicitly states "DynaPulse Model DP500G Non-Invasive Blood Pressure Monitor," indicating a physical hardware device for measuring blood pressure, not solely software.
Based on the provided information, the DynaPulse 500G is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In vitro diagnostics are tests performed on samples such as blood, urine, or tissue that have been taken from the human body. They are used to detect diseases, conditions, or infections.
- DynaPulse 500G Function: The description clearly states the device is a "Non-Invasive Blood Pressure Monitor" that collects and measures "blood pressure, pulser and pressure waveform information." This is done directly on the patient's body (non-invasively), not on a sample taken from the body.
- Lack of IVD Indicators: The description does not mention any analysis of biological samples, chemical reactions, or any other processes typically associated with in vitro diagnostics.
Therefore, the DynaPulse 500G falls under the category of a non-invasive medical device used for physiological monitoring, not an in vitro diagnostic device.
N/A
Intended Use / Indications for Use
The DynaPulse 500G is indicated for trained medical professionals to operate on patient at clinical settings to collect and measure blood pressure, pulse and pressure waveform information. In addition, the DynaPulse 500G is indicated to persons at home who are capable and willing to self-administer this device. No training is required to use the device, but professional advice and experience are required to check and interpret the information delivered.
Product codes
DXN
Device Description
DynaPulse Model DP500G Non-Invasive Blood Pressure Monitor
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Trained medical professionals at clinical settings; persons at home who are capable and willing to self-administer this device.
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies
Not Found
Key Metrics
Not Found
Predicate Device(s)
Not Found
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 870.1130 Noninvasive blood pressure measurement system.
(a)
Identification. A noninvasive blood pressure measurement system is a device that provides a signal from which systolic, diastolic, mean, or any combination of the three pressures can be derived through the use of tranducers placed on the surface of the body.(b)
Classification. Class II (performance standards).
0
Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo features a stylized caduceus symbol, which is a staff with two snakes coiled around it. The words "DEPARTMENT OF HEALTH & HUMAN SERVICES • USA" are arranged in a circular pattern around the symbol. The logo is black and white.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
NOV 0 1 2001
Mr. Robert Duffy Director of Product Development Pulse Metric, Inc. 11777 Sorrento Valley Rd. San Diego, CA 92121
Re: K012498
Trade Name: DynaPulse Model DP500G Non-Invasive Blood Pressure Monitor Regulation Number: 21 CFR 870.1130 Regulation Name: Noninvasive blood pressure measurement system. Regulatory Class: II (two) Product Code: DXN Dated: August 2, 2001 Received: August 3, 2001
Dear Mr. Duffy:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
1
Page 2 - Mr. Robert Duffy
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 21 CFR Part 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4646. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html
Sincerely yours,
Qaki Mellum
James E. Dillard III Director Division of Cardiovascular and Respiratory Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
2
NOV 01 2001
Indications for Use Statement
(US) Foodrand Drug Administrations Center for Devices and Radiological Health,
510(k) Number: K012498
Device Name: DynaPulse 500G (DP500G) Non-Invasive Blood Pressure Monitor
Indications for Use:
The DynaPulse 500G is indicated for trained medical professionals to operate on partient at clinical settings to collect and measure blood pressure, pulser and pressure waveform information. In and willing to collined willing to collined willing to collined willing to col sellings to concer and measure probles, problems at home who are capable and willing to selfaddition, the Dyllar uise 2000 is marcated to purchase week on the device does not send any administrate this device upon present and experience are required to check and interpret the information delivered.
11777 Sorrento Valley Rd., San Diego, CA 92121 USA • Tel: (858)480-1171 • Fax: (858) 480-1147
Prescription Use
(Per 21 CFR 801.109)
Division of Cardiovascular & Respiratory Devices
510(k) Number K012498